Federal Appeals Court Rules Investors can Continue to Bring Claims Against KV Pharmaceutical
The Health Law Firm
JUNE 20, 2012
(KV) for making false or misleading statements to the US Food and Drug Administration (FDA). Appeals Court Ruling Revives Securities Fraud Class Action Lawsuit. In making this decision, the appeals court has renewed a securities fraud class action that was dismissed by a trial court in 2010.
Let's personalize your content